Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer

Yolanda I. Garces, Scott H. Okuno, Steven E. Schild, Sumithra J. Mandrekar, Brian M. Bot, John M. Martens, Donald B. Wender, Gamini S. Soori, Dennis F. Moore, Timothy F. Kozelsky, James R. Jett

Research output: Contribution to journal › Article › peer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy